Do Oxygen Limits Explain Insect Size? A Nature Podcast on Tracheal Diffusion and Size Constraints

The Nature Podcast investigates why giant insects disappeared from the modern world and whether oxygen diffusion truly limits insect size. Researchers examining the tiny air tubes that deliver oxygen to flight muscles find that tracheal investment rises with body size but remains a small fraction of tissue, suggesting oxygen concentration isn’t the primary constraint. The episode also delves into a case where scientists are moving CAR-T therapies from the lab toward in-body genetic engineering, highlighting in vivo delivery and early animal-model results on targeting cancer.

Overview

The podcast surveys a long-standing question in insect biology: why haven’t insects grown to colossal sizes while ancient relatives such as Griffin flies allegedly reached wingspans up to half a meter? A Nature paper is center stage, reexamining the oxygen-diffusion dogma that has framed discussions for decades. The researchers argue that although the tracheal system delivering oxygen to flight muscles becomes denser as insects increase in size, the total investment remains a small fraction of tissue, challenging the idea that atmospheric oxygen limits body size.

"extraordinary claims require extraordinary evidence." - Ned Snelling, Comparative Physiologist

Insects size and the oxygen dogma

The episode outlines the traditional view: diffusion of oxygen through a simple tracheal system could cap size because oxygen diffusion is slow over larger distances. By examining the smallest components of this system, the researchers quantify how much of the flight muscle is devoted to tracheal structures and track how that fraction changes with body mass. They report a rise from about 0.5% in a tiny half-milligram insect to roughly 0.8% in a 5-gram insect, a four-order-of-magnitude mass range that still represents a minor increase. This evidence disputes the idea that more trapped air or atmospheric oxygen is the sole path to bigger insects.

"the investment of tracheoles is only about 0.5% of the flight muscle volume and that it increases to about 0.8%" - Ned Snelling, Comparative Physiologist

Methods, findings, and limitations

To test whether oxygen supply is a bottleneck, the team compared tracheal density across different-sized insects and discussed how these structures function in the flight muscle. They acknowledge potential constraints from air sacs and convection, but argue that the tracheal network’s density could compensate, meaning atmospheric oxygen may not be the limiting factor people once assumed. The discussion also touches on classic objections related to biomechanics and the exoskeleton, and why truly massive insects may be unlikely today due to ecological and mechanical pressures rather than solely diffusion limits.

"predation pressure, which didn't occur 300 million years ago, would stop insects evolving into large body size" - Ned Snelling, Comparative Physiologist

CAR-T therapy in vivo and clinical translation

In a distinct segment, the podcast shifts to immunotherapy and gene therapy. Researchers discuss moving CAR-T cell therapy from ex vivo manufacturing into in-body genetic engineering, using CRISPR to insert CAR genes at a single genomic locus. Animal studies in humanized mice show promising depletion of B cells and responses in lymphoma, myeloma, and solid-tumor models. The team emphasizes translating this approach to non-human primates for regulatory readiness before clinical trials, and notes manufacturing challenges with two-vector systems that could be eased by non-viral strategies.

"the very first time we tested it in a humanized mouse, it works the very first time" - Justin Akim, UCSF

What this means for the future

The episode closes by outlining the road ahead for both fields: a deeper understanding of insect physiology under ecological constraints and the path to safer, scalable in vivo gene therapies. The host invites listeners to consult show notes for links and to follow up on ongoing work in these rapidly advancing areas.